Giacobello Scott M.
Insider CIK 1754154 · GWPH Chief Financial Officer · WHWK Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award | 2026-05-14 | 2026-05-18 | 38,265 | $3.92 | $150.0K | 333,489 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | S Sale | 2026-04-16 | 2026-04-17 | 141,600 | $4.13 | $584.8K | 295,224 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | S Sale | 2026-04-15 | 2026-04-17 | 77,000 | $3.86 | $297.2K | 436,824 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-04-01 | 2026-04-03 | 300,677 | — | $0 | 300,677 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 473,902 | — | $0 | 0 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | M Exercise | 2026-04-01 | 2026-04-03 | 473,902 | — | $0 | 502,002 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | S Sale | 2026-03-02 | 2026-03-10 | 2,594 | $3.31 | $8.6K | 28,100 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | M Exercise deriv | 2026-03-01 | 2026-03-10 | 6,750 | — | $0 | 13,500 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | M Exercise | 2026-03-01 | 2026-03-10 | 6,750 | — | $0 | 30,694 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2025-04-01 | 2025-04-03 | 473,902 | — | $0 | 473,902 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2025-04-01 | 2025-04-03 | 473,902 | — | $0 | 473,902 | SEC↗ |
| AADI Aadi Bioscience, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 2,806 | $2.35 | $6.6K | 23,944 | SEC↗ |
| AADI Aadi Bioscience, Inc. | M Exercise deriv | 2025-03-01 | 2025-03-03 | 6,750 | — | $0 | 20,250 | SEC↗ |
| AADI Aadi Bioscience, Inc. | M Exercise | 2025-03-01 | 2025-03-03 | 6,750 | — | $0 | 26,750 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 27,000 | — | $0 | 27,000 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 138,263 | — | $0 | 138,263 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2023-04-03 | 2023-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2023-03-01 | 2023-03-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award | 2022-09-26 | 2022-09-27 | 20,000 | $12.50 | $250.0K | 20,000 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 46,400 | — | $0 | 46,400 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 43,824 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 83,844 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 12,576 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 144,828 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 86,928 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 10,404 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 70,092 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 8,136 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 44,184 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 68,460 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 67,164 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2021-05-05 | 2021-05-07 | 165,108 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-03-02 | 2021-03-04 | 43,824 | — | $0 | 43,824 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-03-02 | 2021-03-04 | 70,092 | — | $0 | 70,092 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-03-01 | 2021-03-02 | 6,288 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-03-01 | 2021-03-02 | 6,288 | — | $0 | 168,408 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-03-01 | 2021-03-02 | 3,300 | $17.85 | $58.9K | 165,108 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-02-26 | 2021-03-02 | 138,756 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-02-26 | 2021-03-02 | 10,404 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-02-26 | 2021-03-02 | 72,649 | $17.90 | $1.30M | 157,163 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-02-26 | 2021-03-02 | 138,756 | — | $0 | 229,812 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-02-26 | 2021-03-02 | 10,404 | — | $0 | 167,567 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-02-26 | 2021-03-02 | 5,447 | $17.90 | $97.5K | 161,120 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-24 | 70,128 | — | $0 | 70,128 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-24 | 43,812 | — | $0 | 43,812 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-06-04 | 2020-06-08 | 86,928 | — | $0 | 86,928 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-06-04 | 2020-06-08 | 144,828 | — | $0 | 144,828 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-05-18 | 2020-05-20 | 108,468 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-05-18 | 2020-05-20 | 8,136 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2020-05-18 | 2020-05-20 | 53,784 | $9.67 | $520.1K | 86,958 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-05-18 | 2020-05-20 | 8,136 | — | $0 | 95,094 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2020-05-18 | 2020-05-20 | 4,032 | $9.67 | $39.0K | 91,062 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-05-18 | 2020-05-20 | 108,468 | — | $0 | 140,742 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | P Buy | 2020-03-13 | 2020-03-17 | 7,200 | $6.80 | $49.0K | 88,224 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-03-02 | 2020-03-04 | 2,220 | $8.34 | $18.5K | 81,024 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-26 | 2020-02-28 | 228 | $9.17 | $2.1K | 83,244 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-26 | 2020-02-28 | 3,624 | $9.17 | $33.2K | 83,472 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-20 | 2019-05-21 | 4,224 | $14.52 | $61.3K | 87,096 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-18 | 2019-05-21 | 8,136 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-05-18 | 2019-05-21 | 8,136 | — | $0 | 91,320 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 6,288 | — | $0 | 6,288 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 6,288 | — | $0 | 6,288 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 6,288 | — | $0 | 6,288 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 6,288 | — | $0 | 6,288 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 83,844 | — | $0 | 83,844 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 44,184 | — | $0 | 44,184 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-02-26 | 2019-02-28 | 10,404 | — | $0 | 3 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-02-26 | 2019-02-28 | 10,404 | — | $0 | 15,768 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 1,584 | $12.42 | $19.7K | 14,184 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 48 | $12.38 | $594 | 10,536 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 3,600 | $12.46 | $44.9K | 10,584 | SEC↗ |